Cargando…
Bone metastatic carcinoma with EGFR amplification and mutation: A case report and literature review
Mutations in the epidermal growth factor receptor (EGFR) gene are highly prevalent in non-small cell lung cancer, while rare in other cancers. Primarily it’s hardly present in bone metastases from cancer of unknown primary (BMCUP). Currently, no specific treatment options for bone metastases from un...
Autores principales: | Du, Hong-Juan, Chen, Fang-Fang, Liu, Yu, Zhou, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857377/ https://www.ncbi.nlm.nih.gov/pubmed/36701708 http://dx.doi.org/10.1097/MD.0000000000032615 |
Ejemplares similares
-
The content of mutant EGFR DNA correlates with response to EGFR-TKIs in lung adenocarcinoma patients with common EGFR mutations
por: Hung, Ming-Szu, et al.
Publicado: (2016) -
Lung adenocarcinoma with EGFR gene mutation metastatic to the uterine cervix: A case report
por: Wang, Yong, et al.
Publicado: (2020) -
Marked response to nab-paclitaxel in EGFR mutated lung neuroendocrine carcinoma: A case report
por: Liang, Jin-Yan, et al.
Publicado: (2017) -
Efficacy of 3rd generation TKI in patients with EGFR mutation lung adenocarcinoma with bone metastases: A review of 3 case reports and literature
por: Guo, Qiang, et al.
Publicado: (2023) -
Combination therapy with afatinib and bevacizumab in an EGFR-mutated non-small cell lung cancer patient with acquired ERBB2 amplification: A case report
por: Chen, Sixian, et al.
Publicado: (2021)